Pet Cancer Therapeutics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027) – Yahoo Finance

The pet cancer therapeutics market is estimated to be USD 364. 07 million in 2021. It is expected to reach USD 589. 03 million by 2027, registering a CAGR of 8. 89% from 2022 to 2027. American Veterinary Medical Association 2020, conducted a survey for practice owners wherein it was concluded that an increasing number of veterinary practices are using telemedicine, and precautionary lockdown measures are being carried out with only critical cases being attended on in personal basis.
New York, July 25, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Pet Cancer Therapeutics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” – https://www.reportlinker.com/p06309361/?utm_source=GNW
However, COVID-19, being a pandemic is having a slightly negative impact on the pet cancer therapeutics market. The diagnosis and treatment procedures are witnessing decreasing rates. The pandemic has disrupted the spectrum of cancer care, including delays in diagnosis and treatment and slow clinical trials.

The growing prevalence of several types of cancers in cats and dogs, as well as an increase in animal health awareness is contributing to the growth of the market. According to the Veterinary Cancer Society, cancer was the leading cause of death in 47% of dogs, especially those that are over the age of 10, and 32% of cats, in 2017. The most common cancers in cats are leukemia and lymphoma.

Similarly, according to the Center for Cancer Research, National Cancer Institute, there are approximately 32 million cats and 65 million dogs in the United States. Out of these, around 6 million new cancer diagnoses are made in dogs and a similar number of diagnoses are made in cats, each year. The American Veterinary Medical Association (AVMA) states that dogs get cancer at almost the same rate as humans. Cancer is found mostly in aging animals, but some breeds have higher rates of cancer than others. In addition to these factors, growing pet health awareness and rise in R&D initiatives regarding pet cancer management are expected to propel market growth over the forecast period. However, side effects caused by drugs used for the treatment of pet cancers, the reluctance of pet owners to put their pet animals under medication is expected to restrain the pet cancer therapeutics market.

Key Market Trends

Cancers in Dogs are Expected to Lead the Market

Dogs get cancer at about the same rate as humans, while cats get fewer cancers. Some breeds or families of dogs have a higher incidence of developing cancer at an earlier age, but in most cases, it’s a disease found in aging animals. As per the non-profit organization FETCH a Cure, an estimated 6 million dogs were diagnosed with cancer in the year 2019 across the globe. This indicates that there is a raising need for cancer treatment in dogs, which is likely to boost the demand for cancer therapeutics.

In addition, there is an increase in the adoption of dogs around the world. As per the People’s Dispensary for Sick Animals, in 2011, there had been 8.3 million pet dogs in the United Kingdom, which increased to 9.9 million by 2019. Also, Australia is known to have the highest rate of pet ownership in the world. There are around 24 million pets in the country, and dogs are the most common among them. There are approximately 4.8 million pet dogs in Australia, which also represents a high number of pet dogs.

There is also an increase in research and development initiatives regarding pet cancer management by the players that are expected to propel the market growth, over the forecast period. For instance, in April 2019 Elanco has signed a development and commercialization agreement with VetDC for Tanovea-CA1, the first U.S. Food and Drug Administration (FDA) conditionally approved canine lymphoma treatment.

North America Dominates the Pet Cancer Therapeutics Market

Geographically, North America is expected to retain its significant market share, owing to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. The American Pet Products Association suggested that around 67% of the US households, or about 85 million families, own a pet, as of 2019. Among these, 63.4 million are dogs, which is the highest in number among pets owned. Also, according to the Animal Cancer Foundation 2018 report, 65 million dogs and 32 million cats in the United States are diagnosed with cancer. Moreover, approximately 6 million new cancer diagnoses are made in pets every year.

In addition, the rise in the prevalence of various animal diseases and injuries has been identified as the major factor fueling the market growth. In addition, the North American Pet Health Insurance Association (NAPHIA), in 2019, reported that the adoption rates of pet health insurance are increased over the years in this region. In 2019, in the United States, the pet insurance rate was about 2.3% in dogs compared to 1.7% in 2017, whereas the cat insurance rate was 0.4% in cats compared to 0.3% in the year 2017.

Moreover, the data published by American Pet Products Association (APPA), in 2019, stated that the total pet healthcare expenditure is estimated to be USD 75.38 billion by the end of the year, while the expenditure in 2018 was USD 72.56 billion. North America also emphasizes establishing proper skills among veterinary practitioners. Hence, all these factors are driving the growth of the pet cancer therapeutics market in North America.

Competitive Landscape

The market players in the pet cancer therapeutics market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers and acquisitions in order to enhance the market presence. Some of the companies which are currently dominating the market are Boehringer Ingelheim GmbH, Elanco, Zoetis, AB Science, Elekta AB, among others

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support
Read the full report: https://www.reportlinker.com/p06309361/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Logitech International chief Bracken Darrell remains confident about the company's growth potential, despite the computer peripherals maker reporting a drop in sales and profits and cutting its guidance for a second time this year. The Swiss-American company had been hit by a stronger dollar, which had a translation effect, as well as higher inflation and lower consumer confidence, Darrell told Reuters on Tuesday. Logitech enjoyed rapid growth in the pandemic years as customers equipped home offices and played games online.
It's not necessary to spend a ton to find a last minute gift. Shop these best — and cheap — gifts under $20, including Amazon and lab-tested finds for him or her.
Merck, Novartis and others are seeking to revive the $48 billion market, which had shrunk after top-selling cholesterol and other drugs lost patent protection.
Cesar Millan is no longer in the legal doghouse. The expert dog trainer is breathing a massive sigh of relief after a lawsuit filed against him was signed, sealed and settled. According to legal documents obtained by The Blast, Millan’s future dates in court regarding the lawsuit have been taken off the official court calendar. […]
Readers are continuing to discuss The Times' reporting on alarming conditions in the city of Los Angeles' animal shelters.
Shares of Seagen Inc. gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in combination with Merck & Co. Inc.'s Keytruda met its primary endpoint. Seagen is developing the therapy, enfortumab vedotin, with Astellas Pharma Inc. ; it received a Breakthrough Therapy designation in early 2020. The company said in a news release that the combination therapy generated a 64.5% confirmed objectiv
These products that manage pet hair will help keep your house and clothing clean so you can enjoy your furry friends.
You may be surprised that some well-meaning things you do might actually be pretty rude to your local grocery worker.
A giant Mega Millions lottery jackpot ballooned to $1.02 billion after no one matched all six numbers Tuesday night and won the top prize. The new estimated jackpot will be the nation’s fourth-largest lottery prize. Tuesday’s numbers were: 07-29-60-63-66, Mega Ball: 15.
Research Highlights: Frequent or usual daytime napping in adults was associated with a 12% higher risk of developing high blood pressure and a 24% high risk of having a stroke compared to never napping. Experts say napping, though not unhealthy, may …
Dollar stores are known for their incredible deals — but there are ways to save even more on their already low prices. Check Out: 20 Best Places To Live on Only a Social Security CheckFind: How Rich…
With the Mega Millions jackpot now up to $810 million, lottery fever is in the air. Despite low odds, experts explain how winning is a "powerful fantasy."
I am not diabetic. Nor am I prediabetic. I do however have a sugar problem. I start my day with croissants; chocolate, almond, even plain if there’s raspberry jam to go with it. I’ve long suspected that my diet habits at work have me on a glucose roller coaster. My job as a writer is conducive to a lot of sitting and snacking.
Nearly two-thirds of bladder cancer patients responded to a combination from Seagen and Merck, leading SGEN stock to jump Tuesday.
High blood sugar—known as hyperglycemia—is associated with type 2 diabetes and can be very dangerous if left untreated. "As medical science has advanced, there has become a big push to get tighter and tighter control of blood sugar levels," says John P. Cunha, DO, FACOEP. "The highs and lows needed to be smoothed out to get as close to normal physiology as possible. This has become the mantra for diabetic care. Just like an elite athlete who is always training, the person with diabetes always ne
Many people swear by this humble pantry—and medicine cabinet—staple. Here's what it can do for your skin, according to a dermatologist.
How is monkeypox spread? What caused the 2022 outbreak? Here is a look at the myths versus the facts surrounding the monkeypox virus according to health officials.
Research Highlights: Researchers have demonstrated for the first time a potential route of the SARS-CoV-2 spike protein damaging the heart. In study evaluating mice and human heart cells, the SARS-CoV-2 spike protein inflamed the heart muscle cells,…
This fox is the third animal in Lexington County to test positive for rabies in 2022, according to the South Carolina Department of Health and Environmental Control.
Surgery was needed to remove a ‘substantial part of my thyroid’, writes Kushner

source